Minerva Neurosciences
NERV | NASDAQ
$2.20
-$0.10 (-4.35%)
At close: Nov 16, 2026, 4:00 PM ET
$2.21
+$0.01 (+0.45%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-4.35%
(1D)No price chart data available for 1D timeframe.
Rating
25.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #923/1021 (Top 90%)
Key Statistics
Market Data
Market Cap $109.64M
1D Range
2.18 2.30
52W Range
2.18 8.07
Valuation (TTM)
PE -0.08
PB -0.00
EV/EBITDA -0.08
Valuation (NTM)
Forward PE N/A
Forward PEG -0.00
Price Target $10.00
Cash Flow
FCF Yield -24559.1%
SBC Adj. FCF Yield -37503.3%
SBC Impact -52.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -136.8% |
-40.7%
FCF 3Y | 5Y -130.1% |
-93.1%
Returns
ROA -295.9%
ROE 167.7%
ROIC -43.6%
Financial Health
Net Cash
$76.95M
Current Ratio 33.02
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders af...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jul 1, 2014
Website www.minervaneurosciences.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$10.00
Upside
+354.55%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NERV